AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Insu-GM1 Tablet ER

Prescription Icon
Prescription Required

Marketer

Olens Healthcare Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Insu-GM1 Tablet ER

Diabetol Duo ER tablets are classified as antidiabetic medications, a dual-agent formulation for adult type 2 diabetes management. This medication assists in regulating blood glucose. Diabetol Duo ER should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical consultation may elevate glucose levels, potentially leading to complications like nephropathy, retinopathy, neuropathy, and peripheral vascular disease. Remember, it’s a component of a comprehensive program encompassing dietary adjustments, physical activity, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a frequent adverse effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available fast-acting glucose sources (e.g., sugary foods, fruit juice) are essential. Alcohol consumption increases hypoglycemia risk and should be minimized. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring, along with blood cell and liver function tests as deemed necessary by your doctor, are recommended.

Uses of Insu-GM1 Tablet ER

Managing type 2 diabetes

Major Benefits of Insu-GM1 Tablet ER:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Consume Insu-GM1 Tablet ER with a meal.

Common Side effects of Insu-GM1 Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Insu-GM1 Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. It's recommended to take Insu-GM1 Tablet ER with a meal.

How Insu-GM1 Tablet ER works:

Insu-GM1 Extended-Release tablets contain glimepiride and metformin, two medications that manage blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to produce more insulin, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Insu-GM1 Tablet ER is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Insu-GM1 Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Extended-release Insu-GM1 tablets are contraindicated during lactation. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving may be impaired by abnormally low or high blood sugar levels. Refrain from driving if you experience such symptoms.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Insu-GM1 Extended-Release tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Insu-GM1 Extended-Release tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Insu-GM1 Extended-Release tablets cautiously, potentially requiring dosage modification. Consult a physician. A low initial dose is generally recommended for individuals with mild to moderate hepatic dysfunction; the medication is contraindicated in those with severe liver disease.

What if you forget to take Insu-GM1 Tablet ER :

Should you forget to take your Insu-GM1 Tablet ER, ingest it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Never take a double dose.

Facts to Know About Insu-GM1 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Insu-GM1 Tablet ER

Store this medication in its original, tightly closed container, following the instructions on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Insu-GM1 Tablet ER can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Insu-GM1 Tablet ER and seek immediate medical attention.
Insu-GM1 ER tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Insu-GM1 ER is not suitable for type 1 DM.
Insu-GM1 Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Insu-GM1 Tablet ER use can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate this risk, supplemental Vitamin B12 is recommended at least annually.
Insu-GM1 Tablet ER can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Insu-GM1 Tablet ER and alcohol is unsafe. Alcohol can worsen the medication's blood sugar-lowering effect, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Insu-GM1 Tablet ER
35
MRP 40
12% off